S2Medical AB Secures New Loan Agreement and Aims to be Debt-Free by July 2024
S2Medical AB (publ) ("S2Medical") is proud to announce the signing of a new loan agreement. This agreement replaces the previous one, which expired in December 2022. With this new financing structure, it is the Company's intention that, after an initial repayment, a remaining loan debt of approximately SEK 8.1 million will be retained. The loan carries a monthly interest rate of 3% until December 2023 and will be reduced to 1.5% thereafter. The agreement stipulates that a portion of the original loan will be repaid using funds from the cash received from the rights issue that the